Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 1/2 3Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 120Mesothelioma 70Solid Tumor 46Solid Tumors 33Retinoblastoma 27Solitary Fibrous Tumor, Pleural 20Sarcoma 17Advanced Solid Tumor 16Advanced Solid Tumors 15Lung Neoplasms 13Small Cell Lung Carcinoma 12Carcinoma, Non-Small-Cell Lung 11Osteosarcoma 9Neuroblastoma 8Ovarian Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 6Solid Tumor, Adult 6Colorectal Neoplasms 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 5Thyroid Neoplasms 5Stomach Neoplasms 5Neoplasms 5Melanoma 5Medulloblastoma 5Chondrosarcoma 5Carcinoma, Hepatocellular 5Breast Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Malignant Solid Tumour × Other solid neoplasm × Clear all
NCT02853903 2019-09-12

Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors

Fuda Cancer Hospital, Guangzhou

Phase 2 Completed
20 enrolled
Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡